IMPROVEjob - Participatory intervention to improve job satisfaction of general practice teams: a model for structural and behavioural prevention in small and medium-sized enterprises - a study protocol of a cluster-randomised controlled trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
16 Jun 2020
Historique:
received: 27 02 2020
accepted: 16 05 2020
entrez: 18 6 2020
pubmed: 18 6 2020
medline: 12 3 2021
Statut: epublish

Résumé

Perceived high chronic stress is twice as prevalent among German general practitioners (GPs) and non-physician medical staff compared to the general population. The reasons are multi-factorial and include patient, practice, healthcare system and societal factors, such as multi-morbidity, the diversity of populations and innovations in medical care. Also, practice-related factors, like stressful patient-staff interactions, poor process management of waiting times and lack of leadership, play a role. This publicly funded study evaluates the effectiveness of the newly developed participatory, interdisciplinary, and multimodal IMPROVEjob intervention on improving job satisfaction among general practice personnel. The intervention aims at structural stress prevention with regard to working conditions and behavioural stress prevention for leaders and other practice personnel. In this cluster-randomised controlled trial, a total of 56 general practices will be assigned to either (1) participation in the IMPROVEjob intervention or (2) the waiting-list control group. The IMPROVEjob intervention consists of the following elements: three workshops, a toolbox with supplemental material and an implementation period with regular contact to so-called IMPROVEjob facilitators. The first workshop, addressing leadership issues, is designed for physicians with leadership responsibilities only. The two subsequent workshops target all GP and non-physician personnel; they address issues of communication (with patients and within the team), self-care and team-care and practice organisation. During the 9-month implementation period, practices will be contacted by IMPROVEjob facilitators to enhance motivation. Additionally, the practices will have access to the toolbox materials online. All participants will complete questionnaires at baseline and follow up. The primary outcome is the change in job satisfaction as measured by the respective scale of the validated German version of the Copenhagen Psychosocial Questionnaire (COPSOQ, version 2018). Secondary outcomes obtained by questionnaires and - qualitatively - by facilitators comprise psychosocial working conditions including leadership aspects, expectations and experiences of the workshops, team and individual efforts and organisational changes. It is hypothesised that participation in the IMPROVEjob intervention will improve job satisfaction and thus constitute a structural and behavioural prevention strategy for the promotion of psychological wellbeing of personnel in general practices and prospectively in other small and medium sized enterprises. German Clinical Trials Register: DRKS00012677. Registered on 16 October 2019. Retrospectively, https://www.drks.de/drks_web/navigate.do?navigationId=trial. HTML&TRIAL_ID = DRKS00012677.

Sections du résumé

BACKGROUND BACKGROUND
Perceived high chronic stress is twice as prevalent among German general practitioners (GPs) and non-physician medical staff compared to the general population. The reasons are multi-factorial and include patient, practice, healthcare system and societal factors, such as multi-morbidity, the diversity of populations and innovations in medical care. Also, practice-related factors, like stressful patient-staff interactions, poor process management of waiting times and lack of leadership, play a role. This publicly funded study evaluates the effectiveness of the newly developed participatory, interdisciplinary, and multimodal IMPROVEjob intervention on improving job satisfaction among general practice personnel. The intervention aims at structural stress prevention with regard to working conditions and behavioural stress prevention for leaders and other practice personnel.
METHODS METHODS
In this cluster-randomised controlled trial, a total of 56 general practices will be assigned to either (1) participation in the IMPROVEjob intervention or (2) the waiting-list control group. The IMPROVEjob intervention consists of the following elements: three workshops, a toolbox with supplemental material and an implementation period with regular contact to so-called IMPROVEjob facilitators. The first workshop, addressing leadership issues, is designed for physicians with leadership responsibilities only. The two subsequent workshops target all GP and non-physician personnel; they address issues of communication (with patients and within the team), self-care and team-care and practice organisation. During the 9-month implementation period, practices will be contacted by IMPROVEjob facilitators to enhance motivation. Additionally, the practices will have access to the toolbox materials online. All participants will complete questionnaires at baseline and follow up. The primary outcome is the change in job satisfaction as measured by the respective scale of the validated German version of the Copenhagen Psychosocial Questionnaire (COPSOQ, version 2018). Secondary outcomes obtained by questionnaires and - qualitatively - by facilitators comprise psychosocial working conditions including leadership aspects, expectations and experiences of the workshops, team and individual efforts and organisational changes.
DISCUSSION CONCLUSIONS
It is hypothesised that participation in the IMPROVEjob intervention will improve job satisfaction and thus constitute a structural and behavioural prevention strategy for the promotion of psychological wellbeing of personnel in general practices and prospectively in other small and medium sized enterprises.
TRIAL REGISTRATION BACKGROUND
German Clinical Trials Register: DRKS00012677. Registered on 16 October 2019. Retrospectively, https://www.drks.de/drks_web/navigate.do?navigationId=trial. HTML&TRIAL_ID = DRKS00012677.

Identifiants

pubmed: 32546256
doi: 10.1186/s13063-020-04427-7
pii: 10.1186/s13063-020-04427-7
pmc: PMC7298849
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

532

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1851D, 01GL1751B, 01GL1751A, 01GL1751C

Investigateurs

M A Rieger (MA)
E Rind (E)
A Siegel (A)
A Wagner (A)
E Tsarouha (E)
B Weltermann (B)
S Kasten (S)
K Linden (K)
L Degen (L)
A Thielmann (A)
F Junne (F)
T Seifried-Dübon (T)
A Hermann-Werners (A)
F Stuber (F)
S Zipfel (S)
B Werners (B)
M Grot (M)
K-H Jöckel (KH)
C Pieper (C)
V Schröder (V)
J-M Bois (JM)
A-L Eilerts (AL)
M Brinkmann (M)
C Kersting (C)
S Emerich (S)
S Burgess (S)
M Hippler (M)
A Dreher (A)
C Ose (C)
L Koppka (L)
J Block (J)

Commentaires et corrections

Type : ErratumIn

Références

Int Arch Occup Environ Health. 2011 Jun;84(5):479-90
pubmed: 21445647
BMC Med Res Methodol. 2012 Apr 01;12:42
pubmed: 22463771
J Postgrad Med. 2002 Jul-Sep;48(3):206-8
pubmed: 12432198
Psychother Psychosom. 2015;84(3):167-76
pubmed: 25831962
Int Arch Occup Environ Health. 2012 Jan;85(1):67-79
pubmed: 21584721
J Gen Intern Med. 2009 Dec;24(12):1318-21
pubmed: 19802645
PLoS One. 2018 Oct 26;13(10):e0206412
pubmed: 30365546
Scand J Public Health. 2010 Feb;38(3 Suppl):33-41
pubmed: 21172769
Lancet. 2016 Nov 5;388(10057):2272-2281
pubmed: 27692469
PLoS One. 2017 May 10;12(5):e0176658
pubmed: 28489939
J Gen Intern Med. 2012 Nov;27(11):1445-52
pubmed: 22362127
Explore (NY). 2010 Jul-Aug;6(4):225-6
pubmed: 20633836
Eur J Gen Pract. 2006;12(4):174-80
pubmed: 17127604
Am J Public Health. 1998 Mar;88(3):382-8
pubmed: 9518968
BMC Fam Pract. 2019 Aug 9;20(1):96
pubmed: 31395016
BMC Fam Pract. 2015 Nov 11;16:166
pubmed: 26560752
J Contin Educ Health Prof. 2014 Winter;34(1):4-12
pubmed: 24648359
J Clin Epidemiol. 1996 Apr;49(4):435-9
pubmed: 8621994
Psychosoc Med. 2006 Oct 18;3:Doc05
pubmed: 19742072
Occup Environ Med. 2017 Mar;74(4):301-310
pubmed: 28108676
Saf Health Work. 2019 Dec;10(4):482-503
pubmed: 31890332
PLoS One. 2017 Aug 25;12(8):e0183019
pubmed: 28841662
Lancet. 2009 Nov 14;374(9702):1714-21
pubmed: 19914516
Med Klin (Munich). 2010 Nov;105(11):767-71
pubmed: 21136233
Front Psychiatry. 2019 Sep 03;10:622
pubmed: 31551829
Qual Life Res. 2012 Apr;21(3):487-94
pubmed: 21710355
Psychol Med. 2007 Aug;37(8):1119-29
pubmed: 17407618
BMC Fam Pract. 2019 Oct 24;20(1):143
pubmed: 31651239
Int J Environ Res Public Health. 2018 Sep 27;15(10):
pubmed: 30262790
Psychol Med. 2005 Jun;35(6):865-71
pubmed: 15997606
Br J Gen Pract. 2017 Apr;67(657):e227-e237
pubmed: 28289014
BMC Public Health. 2014 Feb 08;14:135
pubmed: 24507447
JAMA Intern Med. 2017 Feb 1;177(2):195-205
pubmed: 27918798
PLoS One. 2019 Feb 6;14(2):e0211223
pubmed: 30726284
Int J Nurs Pract. 2016 Dec;22(6):538-545
pubmed: 27241867
Int Arch Occup Environ Health. 2012 Nov;85(8):865-76
pubmed: 22205341
J Gen Intern Med. 2015 May;30(5):656-74
pubmed: 25527339
BMC Fam Pract. 2016 Sep 13;17(1):133
pubmed: 27619913
Trials. 2016 Feb 09;17:72
pubmed: 26862034
Scand J Public Health. 2010 Feb;38(3 Suppl):120-4
pubmed: 21172777
BMC Health Serv Res. 2019 Jan 21;19(1):53
pubmed: 30665401
Fam Pract. 2000 Apr;17(2):192-6
pubmed: 10758085

Auteurs

Birgitta M Weltermann (BM)

Institute of General Practice and Family Medicine, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. birgitta.weltermann@ukbonn.de.
Institute for General Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstr 55, 45122, Essen, Germany. birgitta.weltermann@ukbonn.de.

Christine Kersting (C)

Institute for General Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstr 55, 45122, Essen, Germany.

Claudia Pieper (C)

Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Hufelandstr 55, 45147, Essen, Germany.

Tanja Seifried-Dübon (T)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tuebingen, Osianderstraße 5, 72076, Tuebingen, Germany.

Annegret Dreher (A)

Institute of General Practice and Family Medicine, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.

Karen Linden (K)

Institute of General Practice and Family Medicine, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.

Esther Rind (E)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tuebingen, Wilhelmstr 27, 72074, Tuebingen, Germany.

Claudia Ose (C)

Center for Clinical Trials, University Hospital Essen, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.

Karl-Heinz Jöckel (KH)

Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Hufelandstr 55, 45147, Essen, Germany.
Center for Clinical Trials, University Hospital Essen, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.

Florian Junne (F)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tuebingen, Osianderstraße 5, 72076, Tuebingen, Germany.

Brigitte Werners (B)

Institute for Operations Research, Ruhr University Bochum, Universitätsstr 150, 44801, Bochum, Germany.

Verena Schroeder (V)

Center for Clinical Trials, University Hospital Essen, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.

Jean-Marie Bois (JM)

Center for Clinical Trials, University Hospital Essen, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.

Achim Siegel (A)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tuebingen, Wilhelmstr 27, 72074, Tuebingen, Germany.

Anika Thielmann (A)

Institute of General Practice and Family Medicine, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.

Monika A Rieger (MA)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tuebingen, Wilhelmstr 27, 72074, Tuebingen, Germany.

Stefanie Kasten (S)

Institute of General Practice and Family Medicine, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH